Rationale of a phase III study comparing a standard cisplatin regimen (mitomycin/ifosfamide/cisplatin) with cisplatin and gemcitabine in non-small cell lung cancer

被引：0
|
作者：
Tonato, M
Crino, L
Mosconi, AM
机构：
来源：
SEMINARS IN ONCOLOGY | 1997年 / 24卷 / 03期
关键词：
RANDOMIZED TRIAL; ACTIVE REGIMENS;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：831 / 835
页数：5
相关论文
共 50 条
  • [11] MITOMYCIN, IFOSFAMIDE AND CISPLATIN IN NON-SMALL-CELL LUNG-CANCER
    CURRIE, DC
    MILES, DW
    DRAKE, JS
    RUDD, R
    SPIRO, SG
    EARL, HM
    HARPER, PG
    TOBIAS, JS
    SOUHAMI, RL
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (05) : 380 - 381
  • [12] Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma
    Danson, S
    Middleton, MR
    O'Byrne, KJ
    Clemons, M
    Ranson, M
    Hassan, J
    Anderson, H
    Burt, PA
    Fairve-Finn, C
    Stout, R
    Dowd, I
    Ashcroft, L
    Beresford, C
    Thatcher, N
    CANCER, 2003, 98 (03) : 542 - 553
  • [13] A phase II study of gemcitabine with cisplatin in patients with non-small cell lung cancer
    Abratt, RP
    Bezwoda, WR
    Goedhals, L
    Hacking, DJ
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1086 - 1086
  • [14] COMBINATION CHEMOTHERAPY WITH IFOSFAMIDE, MITOMYCIN, AND CISPLATIN IN ADVANCED NON-SMALL CELL LUNG-CANCER
    GIRON, CG
    ORDONEZ, A
    JALON, JI
    BARON, MG
    CANCER TREATMENT REPORTS, 1987, 71 (09): : 851 - 853
  • [15] Gemcitabine plus cisplatin in non-small cell lung cancer: A Phase II study
    Sandler, A
    Ansari, R
    McClean, J
    Fisher, W
    Dorr, FA
    Einhorn, LH
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1079 - 1079
  • [16] Phase II study of Gemcitabine, ifosfamide and cisplatin (GIP) in patients with advanced non-small cell lung cancer (NSCLC)
    De las Penas, R
    Busquier, I
    Munarriz, J
    Lopez, A
    Llorente, R
    Alberola, V
    Frau, A
    ANNALS OF ONCOLOGY, 1998, 9 : 88 - 88
  • [17] Induction chemotherapy with the TIP regimen (paclitaxel/ifosfamide/cisplatin) in stage III non-small cell lung cancer
    Pohl, G
    Krajnik, G
    Malayeri, R
    Doweik, L
    Müller, RM
    Klepetko, W
    Eckersberger, F
    Schäffer-Prokop, C
    Schmeikal, S
    Smolle-Jüttner, FM
    Maier, A
    Ambrosch, G
    Woltsche, M
    Minar, W
    Pirker, R
    8TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2002, : 237 - 244
  • [18] Induction chemotherapy with the TIP regimen (pactitaxel/ifosfamide/cisplatin) in stage III non-small cell lung cancer
    Pohl, Gudrun
    Krajnik, Gerhard
    Malayeri, Reza
    Mueller, Rolf-Michael
    Klepetko, Walter
    Eckersberger, Franz
    Schaefer-Prokop, Cornelia
    Pokrajac, Boris
    Schmeikal, Susanne
    Maier, Alfred
    Ambrosch, Gerhard
    Woltsche, Michael
    Minar, Wilma
    Pirker, Robert
    LUNG CANCER, 2006, 54 (01) : 63 - 67
  • [19] A phase II trial of the combination of gemcitabine, ifosfamide and cisplatin in the treatment of advanced non-small cell lung cancer
    Vadell-Nadal, C
    Nogué-Aliguer, M
    Fabregat-Mayol, X
    Saigí-Grau, E
    Gallén-Castillo, M
    LUNG CANCER, 2000, 28 (02) : 109 - 115
  • [20] Vinorelbine, ifosfamide and cisplatin in advanced non-small cell lung cancer
    Tan, EH
    Ang, PT
    Wee, J
    Fong, KW
    Leong, SS
    Khoo, KS
    ACTA ONCOLOGICA, 1999, 38 (05) : 619 - 622
12345